Crucial role of impaired Kupffer cell phagocytosis on the decreased Sonazoid-enhanced echogenicity in a liver of a nonalchoholic steatohepatitis rat model

Hepatology Research

Volumn 40, Issue 8, 2010, Pages 823-831

  Yoshikawa, Shohei ^a   Iijima, Hiroko ^a   Saito, Masaki ^a   Tanaka, Hironori ^a   Imanishi, Hiroyasu ^a   Yoshimoto, Naoki ^a   Yoshimoto, Tomohiro ^a   Futatsugi Yumikura, Shizue ^a   Nakanishi, Kenji ^a   Tsujimura, Tohru ^a   Nishigami, Takashi ^a   Kudo, Atsushi ^b   Arii, Shigeki ^b   Nishiguchi, Shuhei ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Kupffer cells; Nonalcoholic steatohepatitis; Phagocytosis; Sonazoid; Ultrasound contrast agents

Indexed keywords

CHOLINE; FLUORESCEIN ISOTHIOCYANATE; METHIONINE; PERFLUBUTANE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ECHOGRAPHY; FLOW CYTOMETRY; KUPFFER CELL; LIVER PARENCHYMA; MALE; MICROBUBBLE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT;

EID: 77955251568     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2010.00670.x     Document Type: Article

References (31)

1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980, 55:434-8.
2. Bugianesi E, Leone N, Vanni E. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002, 123:134-40.
3. Shimada M, Hashimoto E, Taniai M. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 2002, 37:154-60.
4. Saadeh S, Younossi ZM, Remer EM. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002, 123:745-50.
5. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroentero 1999, 94:2467-74.
6. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999, 116:1413-9.
7. Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009, 51:433-5.
8. Iijima H, Moriyasu F, Miyahara T, Yanagisawa K. Ultrasound contrast agent, Levovist microbubbles are phagocytosed by Kupffer cells-In vitro and in vivo studies. Hepatol Res 2006, 35:235-7.
9. Iijima H, Moriyasu F, Tsuchiya K, Suzuki S, Yoshida M. Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis. Hepatol Res 2007, 37:722-30.
10. Tsujimoto T, Kawaratani H, Kitazawa T. Decreased phagocytic activity of Kupffer cells in a rat nonalcoholic steatohepatitis model. World J Gastroenterol 2008, 14:6036-43.
11. Yanagisawa K, Moriyasu F, Miyahara T, Yuki M, Iijima H. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol 2007, 33:318-25.
12. Watanabe R, Matsumura M, Munemasa T, Fujimaki M, Suematsu M. Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in rat liver. Invest Radiol 2007, 42:643-51.
13. Weltman MD, Farrell GC, Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 1996, 111:1645-53.
14. Sasaki S, Iijima H, Moriyasu F, Hidehiko W. Definition of contrast enhancement phases of the liver using a perfluoro-based microbubble agent. Ultrasound Med Biol 2009, 35:1819-27.
15. Tsutsui H, Mizoguchi Y, Morisawa S. Importance of direct hepatocytolysls by liver macrophages in experimental fulminant hepatitls. Hepatogastroenterology 1992, 39:553-9.
16. Skelly MM, James PD, Ryder SD. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. J Hepatol 2001, 35:195-9.
17. Green RM. NASH:hepatic metabolism and not simply the metabolic syndrome. Hepatology 2003, 38:14-7.
18. Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol 2004, 2:1048-58.
19. Harvey CJ, Blomley MJ, Eckersley RJ, Heckemann RA, Butler-Barnes J, Cosgrove DO. Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases. Lancet 2000, 355:807-8.
20. Gaiani S, Celli N, Piscaglia F. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 2004, 41:421-6.
21. Taylor KJ, Carpenter DA, Hill CR, McCready VR. Gray scale ultrasound imaging. The anatomy and pathology of the liver. Radiology 1976, 119:415-23.
22. Joseph AE, Dewbury KC, McGuire PG. Ultrasound in the detection of chronic liver disease (the 'bright liver'). Br J Radiol 1979, 52:184-8.
23. Foster KJ, Dewbury KC, Griffith AH, Wright R. The accuracy of ultrasound in the detection of fatty infiltration of the liver. Br J Radiol 1980, 53:440-2.
24. Yajima Y, Ohta K, Narui T, Abe R, Suzuki H, Ohtsuki M. Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast. Tohoku J Exp Med 1983, 139:43-50.
25. Ricci C, Longo R, Gioulis E. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol 1997, 27:108-13.
26. Otogawa K, Kinoshita K, Fujii H. Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis. Am J Pathol 2007, 170:967-80.
27. Sontum PC, Ostensen J, Dyrstad K, Hoff L. Acoustic properties of NC100100 and their relation with the microbubble size distribution. Invest Radiol 1999, 34:268-75.
28. Sontum PC. Physicochemical characteristics of Sonazoid, a new contrast agent for ultrasound imaging. Ultrasound Med Biol 2008, 34:824-33.
29. Ijaz S, Yang W, Winslet MC, Seifalian AM. Impairment of hepatic microcirculation in fatty liver. Microcirculation 2003, 10:447-56.
30. McCuskey RS, Ito Y, Robertson GR, McCuskey MK, Perry M, Farrell GC. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. Hepatology 2004, 40:386-93.
31. Farrell GC, Teoh NC, McCuskey RS. Hepatic microcirculation in fatty liver disease. Anat Rec (Hoboken) 2008, 291:684-92.